| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |